References

1. Sharifi-Rad, J.; Cruz-Martins, N.; López-Jornet, P.; Pons-Fuster Lopez, E.; Harun, N.; Yeskaliyeva, B.; Beyatli, A.; Sytar, O.; Shaheen, S.; Sharopov, F.; et al. Natural coumarins: Exploring the pharmacological complexity and underlying molecular mechanisms. Oxid. Med. Cell. Longev. 2021, 2021, 6492346.
2. Dawidowicz, A.L.; Bernacik, K.; Typek, R. Umbelliferone instability during an analysis involving its extraction process. Monatsh. Chem. 2018, 149, 1327–1340.
3. Mazimba, O. Umbelliferone: Sources, chemistry and bioactivities review. Bull. Fac. Pharm. Cairo Univ. 2017, 55, 223–232.
4. Radha, G.V.; Sadhana, B.; Trideva Sastri, K.; Ganapaty, S. Biooactive umbelliferone and its derivatives: An update. J. Pharmacogn. Phytochem. 2019, 8, 59–66.
5. Lin, Z.; Zheng, H. Umbelliferon: A review of its pharmacology, toxicity and pharmacokinetics. Inflammopharmacology 2023, 31, 1731–1750.
6. Fylaktakidou, K.C.; Hadjipavlou-Litina, D.J.; Litinas, K.E.; Nicolaides, D.N. Natural and synthetic coumarin derivatives with anti-inflammatory/antioxidant activities. Curr. Pharm. Des. 2004, 10, 3813–3833.
7. Emami, S.; Dadashpour, S. Current developments of coumarin-based anti-cancer agents in medical chemistry. Eur. J. Med. Chem. 2015, 102, 611–630.
8. Pan, Y.; Liu, T.; Wang, X.; Sun, J. Research progress of coumarins and their derivatives in the treatment of diabetes. J. Enzyme Inhib. Med. Chem. 2022, 37, 616–628.
9. Genovese, S.; Epifano, F.; Curini, M.; Dudra-Jastrzebska, M.; Luszczki, J.J. Prenyloxyphenylpropanoids as a novel class of anticonvulsive agents. Bioorg. Med. Chem. Lett. 2009, 19, 5419–5422.
10. Alipour, M.; Khoobi, M.; Moradi, A.; Nadri, H.; Moghadam, F.H.; Emami, S.; Hasanpour, Z.; Foroumadi, A.; Shafiee, A. Synthesis and anticholinesterase activity of new 7-hydroxycoumarin derivatives. Eur. J. Med. Chem. 2014, 82, 536–544.
11. Wang, X.; Zhou, H.; Wang, X.; Lei, K.; Wang, S. Design, synthesis, and in vivo and in silico evaluation of coumarin derivatives with potential antidepressant effects. Molecules 2021, 26, 5556.
12. Vasconcelos, J.F.; Teixeira, M.M.; Barbosa-Filho, J.M.; Agra, M.F.; Nunes, X.P.; Giulietti, A.M.; Ribeiro-dos-Santos, R.; Soares, M.B.P. Effects of umbelliferone in a murine model of allergic airway inflammation. Eur. J. Pharmacol. 2009, 609, 126–131.
13. Zinovieva, M.L.; Zhminko, P.G. Single and repeat dose toxicity study of 7-hydroxycoumarin, ethanol, and their mixture in rats. J. Pharm. Pharmacol. 2017, 5, 237–244.
14. Cruz, L.F.; de Figueiredo, G.F.; Pedro, L.P.; Amorin, Y.M.; Andrade, J.T.; Passos, T.F.; Rodrigues, F.F.; Souza, I.L.A.R.; Gonçalves, T.P.R.; Dos Santos Lima, L.A.R.; et al. Umbelliferone (7-hydroxycoumarin): A non-toxic antidiarrheal and antiulcerogenic coumarin. Biomed. Pharmacother. 2020, 129, 110432.
15. Chen, L.; Deng, H.; Cui, H.; Fang, J.; Zuo, Z.; Deng, J.; Li, Y.; Wang, X.; Zhao, L. Inflammatory responses and inflammation-associated diseases in organs. Oncotarget 2018, 9, 7204–7218.
16. Kishore, N.; Kumar, P.; Shanker, K.; Kumar Verma, A. Human disorders associated with inflammation and the evolving role of natural products to overcome. Eur. J. Med. Chem. 2019, 179, 272–309.
17. Grover, J.; Jachak, S.M. Coumarins as privileged scaffold for antiinflammatory drug development. RSC Adv. 2015, 5, 38892–38905.
18. Rostom, B.; Karaky, R.; Kassab, I.; Veitía, M.S.-I. Coumarins derivatives and inflammation: Review of their effects on the inflammatory signaling pathways. Eur. J. Pharmacol. 2022, 922, 174867.
19. Di Stasi, L.C. Natural coumarin derivatives activating Nrf2 signaling pathway as lead compounds for the design and synthesis of intestinal anti-inflammatory drugs. Pharmaceuticals 2023, 16, 511.
20. Lee, J.H.; Cho, S.H. Korean red ginseng extract ameliorates skin lesions in NC/ Nga mice: An atopic dermatitis model. J. Ethnopharmacol. 2011, 133, 810–817.
21. Akdis, C.A.; Akdis, M. Mechanisms and treatment of allergic disease in the big picture of regulatory T cells. J. Allergy Clin. Immunol. 2009, 123, 735–746.
22. Huang, Y.; Li, W.; Su, Z.; Kong, A.T. The complexity of the Nrf2 pathway: Beyond the antioxidant response. J. Nutr. Biochem. 2015, 26, 1401–1413.
23. Younas; Khan, A.; Shehzad, O.; Seo, E.K.; Onder, A.; Khan, S. Anti-allergic activities of umbelliferone against histamine- and picryl chloride- induced ear edema by targeting Nrf2/iNOS signaling in mice. BMC Complement. Med. 2021, 21, 215.
24. Bansal, Y.; Sethi, P.; Bansal, G. Coumarin: A potential nucleus for anti-inflammatory molecules. Med. Chem. Res. 2013, 22, 3049–3060.
25. Zhang, H.-J.; Li, Y.-F.; Cao, Q.; Tian, Y.-S.; Quan, Z.-S. Pharmacological evaluation of 9,10-dihydrochromenooxazin-2(8H)-one derivatives as potent anti-inflammatory agent. Pharmacol. Rep. 2017, 69, 419–425.
26. Lawrence, T.; Willoughby, D.A.; Gilroy, D.W. Anti-inflammatory lipid mediators and insights into the resolution of inflammation. Nat. Rev. Immunol. 2002, 2, 787–793.
27. Mu, C.; Wu, M.; Li, Z. Anti-inflammatory effect of novel 7-substituted coumarin derivatives through inhibition of NF-κB signaling pathway. Chem. Biodivers. 2019, 16, e1800559.
28. Gao, F.; Tao, D.; Ju, C.; Yang, B.-B.; Bao, X.-Q.; Zhang, D.; Zhang, T.-T.; Li, L. Regioselectivity of aminomethylation in 3-acetyl-7-hydroxycoumarins: Mannich bases and Betti bases. New J. Chem. 2021, 45, 9864–9871.
29. Sharifi-Rad, M.; Kumar, N.V.A.; Zucca, P.; Varoni, E.M.; Dini, L.; Panzarini, E.; Rajkovic, J.; Fokou, P.V.T.; Azzini, E.; Peluso, I.; et al. Lifestyle, oxidative stress and antioxidants: Back and forth in the pathophysiology of chronic diseases. Front. Physiol. 2020, 11, 694.
30. Forman, H.J.; Zhang, H. Targeting oxidative stress in disease: Promise and limitations od antioxidant therapy. Nat. Rev. Drug Discov. 2021, 20, 689.
31. Al-Majedy, Y.K.; Al-Amiery, A.; Kadhum, A.A.H.; Mohamad, A.B. Antioxidant activities of 4-methylumbelliferone derivatives. PLoS ONE 2016, 11, e0156625.
32. Al-Majedy, Y.K.; Al-Duhaidahawi, D.; Al-Azawi, K.; Al-Amiery, A.A.; Kadhum, A.A.H.; Mohamad, A.B. Coumarins as potential antioxidant agents complemented with suggested mechanisms and approved by molecular modeling studies. Molecules 2016, 21, 135.
33. Kurt, B.Z.; Gazioglu, I.; Kandas, N.O.; Sonmez, F. Synthesis, anticholinesterase, antioxidant, and anti-aflatoxigenic activity of novel coumarin carbamates. ChemistrySelect 2018, 3, 3978–3983.
34. Joy, M.N.; Bodke, Y.D.; Telkar, S.; Bakulev, V.A. Synthesis of coumarins linked with 1,2,3-triazoles under microwave irradiation and evaluation of their antimicrobial and antioxidant activity. J. Mex. Chem. Soc. 2020, 64, 53–73.
35. Kaushik, C.P.; Chahal, M. Synthesis, antimalarial and antioxidant activity of coumarin appended 1,4-disubstituted 1,2,3-triazoles. Mon. Chem. Chem. Mon. 2021, 152, 1001–1012.
36. Kecel-Gunduz, S.; Budama-Kilinic, Y.; Bicak, B.; Gok, B.; Belmen, B.; Aydogan, F.; Yolacan, C. New coumarin derivative with potential antioxidant activity: Synthesis, DNA binding and in silico studies (Docking, MD, ADMET). Arab. J. Chem. 2023, 16, 104440.
37. Kalaiarasi, G.; Rajkumar, S.R.J.; Dharani, S.; Małecki, J.G.; Prabhakaran, R. An investigation on 3-acetyl-7-methoxy-coumarin Shiff bases and their Ru(II) metallates with potent antiproliferative activity and enhanced LDH and NO release. RSC Adv. 2018, 8, 1539–1561.
38. Özdemir, M.; Köksoy, B.; Yalçin, B.; Taşkin, T.; Selçuki, N.A.; Salan, Ü.; Durmuş, M.; Bulut, M. Novel lutetium(III) phthalocyanine-coumarin dyades; synthesis, characterization, photochemical, theoretical and antioxidant activity. Inorg. Chem. Acta 2020, 517, 120145.
39. Ali, M.Y.; Jannat, S.; Jung, H.A.; Choi, R.J.; Roy, A.; Choi, J.S. Anti-Alzheimer’s disease potential of coumarins from Angelica decursiva and Artemisia capillaris and structure-activity analysis. Asian Pac. J. Trop. Med. 2016, 9, 103–111.
40. Ali, M.Y.; Seong, S.H.; Reddy, M.R.; Seo, S.Y.; Choi, J.S.; Jung, H.A. Kinetics and molecular docking studies of 6-formyl umbelliferone isolated from Angelica decursiva as an inhibitor of cholinesterase and BACE1. Molecules 2017, 22, 1604.
41. Karakaya, S.; Koca, M.; Sytar, O.; Duman, H. The natural phenolic compounds and their antioxidant and anticholinesterase potential of herb Leiotulus dasyanthus (K. Koch) Pimenov & Ostr. Nat. Prod. Res. 2020, 1303–1305.
42. Decker, M. Hybrid Molecules for Drug Development; Elsevier Ltd.: New York, NY, USA, 2017; ISBN 9780081011188.
43. Decker, M. Hybrid molecules incorporating natural products: Applications in cancer therapy, neurodegenerative disorders and beyond. Curr. Med. Chem. 2011, 18, 1464–1475.
44. Spilovska, K.; Korabecny, J.; Sepsova, V.; Jun, D.; Hrabinova, M.; Jost, P.; Muckova, L.; Soukup, O.; Janockova, J.; Kucera, T.; et al. Novel tacrine-scutellarin hybrids as multipotent anti-Alzheimer’s agents: Design, synthesis and biological evaluation. Molecules 2017, 22, 1006.
45. Hirbod, K.; Jalili-Baleh, L.; Nadri, H.; Ebrahimi, S.E.S.; Moradi, A.; Pakseresht, B.; Foroumadi, A.; Shafiee, A.; Khoob, M. Coumarin derivatives bearing benzoheterocycle moiety: Synthesis, cholinesterase inhibitory, and docking simulation study. Iran. J. Basic. Med. Sci. 2017, 20, 631–638.
46. Mzezewa, S.C.; Omoruyib, S.I.; Zondagha, L.S.; Malana, S.F.; Ekpoband, O.E.; Joubert, J.J. Design, synthesis, and evaluation of 3,7-substituted coumarin derivatives asmultifunctional Alzheimer’s disease agents. Enzyme Inhib. Med. Chem. 2021, 36, 1606–1620.
47. Seong, S.H.; Ali, M.Y.; Jung, H.A.; Cho, J.S. Umbelliferone derivatives exert neuroprotective effects by inhibiting monoamine oxidase A, self-amyloidβ aggregation, and lipid peroxidation. Bioorg. Chem. 2019, 92, 103293.
48. Dhiman, P.; Malik, N.; Khatkar, A. Exploration of umbelliferone based derivatives as potent MAO inhibitors: Dry vs. wet lab evaluation. Curr. Top. Med. Chem. 2018, 18, 1857–1871.
49. Bester, E.; Petzer, A.; Petzer, J.P. Coumarin derivatives as inhibitors of D-amino acid oxidase and monoamine oxidase. Bioorg. Chem. 2022, 123, 105791.
50. Ostrowska, K.; Leśniak, A.; Czarnocka, Z.; Chmiel, J.; Bujalska-Zadrożny, M.; Trzaskowski, B. Design, synthesis, and biological evaluation of a series of 5- and 7-hydroxycoumarin derivatives as 5-HT1A serotonin receptor antagonists. Pharmaceuticals 2021, 14, 179.
51. Yakovleva, E.E.; Myznikov, L.V.; Shabanov, P.D. Comparison of the anticonvulsant activities of substituted hydroxycoumarins and 4-butanoic acid. Pharm. Chem. J. 2020, 54, 904–908.
52. Ramu, R.; Shirahatti, P.S.; Swamy, S.N.; Zameer, F.; Dhananjaya, B.L.; Prasad, M.N.N. Assessment of in vivo antidiabetic properties of umbelliferone and lupeol constituents of banana (Musa sp. var. Nanjangud Rasa Bale) flower in hyperglycaemic rodent model. PLoS ONE 2016, 11, e0151135.
53. Khadrawy, S.M.; El Sayed, R.A. Umbelliferone attenuates diabetic cardiomyopathy by suppression of JAK/STAT signaling pathway through amelioration of oxidative stress and inflammation in rats. J. Biochem. Mol. Toxicol. 2023, 37, e23296.
54. Ali, M.Y.; Zamponi, G.W.; Seong, S.H.; Jung, H.A.; Choi, J.S. 6-Formyl umbelliferone, a furanocoumarin from Angelica decursiva L., inhibits key diabetes-related enzymes and advanced glycation end-product formation. Molecules 2022, 27, 5720.
55. Wang, G.; Wang, J.; He, D.; Li, X.; Li, J.; Peng, Z. Synthesis, in vitro evaluation and molecular docking studies of novel coumarin-isatin derivatives as α-glucosidase inhibitors. Chem. Biol. Drug Des. 2017, 89, 456–463.
56. Lee, J.H.; Kim, Y.G.; Cho, H.S.; Ryu, S.Y.; Cho, M.H.; Lee, J. Coumarins reduce biofilm formation and the virulence of Escherichia coli O157:H7. Phytomedicine 2014, 21, 1037–1042.
57. Darla, M.M.; Krishna, B.S.; Umamaheswara Rao, K.; Reddy, N.B.; Srivash, M.K.; Adeppa, K.; Sundar, C.S.; Reddy, C.S.; Misra, K. Synthesis and bio-evaluation of novel 7-hydroxy coumarin derivatives via Knoevenagel reaction. Res. Chem. Intermed. 2015, 41, 1115–1133.
58. Sokol, I.; Toma, M.; Krnić, M.; Macan, A.M.; Drenjančević, D.; Liekens, S.; Raić-Malić, S.; Gazivoda Kraljević, T. Transition metal-catalyzed synthesis of new 3-substituted coumarin derivatives as antibacterial and cytostatic agents. Future Med. Chem. 2021, 13, 1865–1884.
59. Farshori, N.N.; Banday, M.R.; Ahmad, A.; Khan, A.U.; Rauf, A. 7-Hydroxy-coumarin derivatives: Synthesis, characterization and preliminary antimicrobial activities. Med. Chem. Res. 2010, 20, 535–541.
60. Soares, V.; Marini, M.B.; de Paula, L.A.; Gabry, P.S.; Amaral, A.C.F.; Malafaia, C.A.; Leal, I.C.R. Umbelliferone esters with antibacterial activity produced by lipase-mediated biocatalytic pathway. Biotechnol. Lett. 2020, 43, 469–477.
61. Shaikh, M.H.; Subhedar, D.D.; Shingate, B.B.; Kalam Khan, F.A.; Sangshetti, J.N.; Khedkar, V.M.; Nawale, L.; Sarkar, D.; Navale, G.R.; Shinde, S.S. Synthesis, biological evaluation and molecular docking of novel coumarin incorporated triazoles as antitubercular, antioxidant and antimicrobial agents. Med. Chem. Res. 2016, 25, 790–804.
62. Gazivoda Kraljević, T.; Harej, A.; Sedić, M.; Kraljević Pavelić, S.; Stepanić, V.; Drenjančević, D.; Talapko, J.; Raić-Malić, S. Synthesis, in vitro anticancer and antibacterial activities and in silico studies of new 4-substituted 1,2,3-triazole-coumarin hybrids. Eur. J. Med. Chem. 2016, 124, 794–808.
63. Hu, Y.; Shen, Y.; Wu, X.; Tu, X.; Wang, G.-X. Synthesis and biological evaluation of coumarin derivatives containing imidazole skeleton as potential antibacterial agents. Eur. J. Med. Chem. 2018, 143, 958–969.
64. El-Sherief, H.A.; Abuo-Rahma, G.E.-D.A.; Shoman, M.E.; Beshr, E.A.; Abdel-baky, R.M. Design and synthesis of new coumarin–chalcone/NO hybrids of potential biological activity. Med. Chem. Res. 2017, 26, 3077–3090.
65. Şahin Gül, D.; Ogutcu, H.; Hayvalı, Z. Investigation of photophysical behaviours and antimicrobial activity of novel benzo-15-crown-5 substituted coumarin and chromone derivatives. J. Mol. Struct. 2020, 1204, 127569.
66. Nath, M.; Jairath, R.; Eng, G.; Song, X.; Kumar, A. Triorganotin(IV) derivatives of umbelliferone (7-hydroxycoumarin) and their adducts with 1,10-phenanthroline: Synthesis, structural and biological studies. J. Organomet. Chem. 2005, 690, 134–144.
67. Yernule, N.G.; Bennikallu Hire Mathada, M. Preparation of octahedral Cu(II), Co(II), Ni(II) and Zn(II) complexes derived from 8-formyl-7-hydroxy-4-methylcoumarin: Synthesis, characterization and biological study. J. Mol. Struct. 2020, 1220, 128659.
68. Klepka, M.T.; Drzewiecka-Antonik, A.; Wolska, A.; Rejmak, P.; Ostrowska, K.; Hejchman, E.; Kruszewska, H.; Czajkowska, A.; Młynarczuk-Biały, I.; Ferenc, W. Synthesis, structural studies and biological activity of new Cu(II) complexes with acetyl derivatives of 7-hydroxy-4-methylcoumarin. J. Inorg. Biochem. 2015, 145, 94–100.
69. El-Attar, M.S.; Sadeek, S.A.; Abd El-Hamid, S.M.; Elshafie, H.S. Spectroscopic analyses and antimicrobial activity of novel ciprofloxacin and 7-hydroxy-4-methylcoumarin, the plant-based natural benzopyrone derivative. Int. J. Mol. Sci. 2022, 23, 8019.
70. Chiang, C.-C.; Cheng, M.-J.; Peng, C.-F.; Huang, H.-Y.; Chen, I.-S. A novel dimeric coumarin analog and antimycobacterial constituents from Fatoua Pilosa. Chem. Biodivers. 2010, 7, 1728–1736.
71. Batra, N.; Rajendran, V.; Wadi, I.; Ghosh, P.C.; Nath, M. Synthesis and antimalarial activity of sulfonamide-attached coumarin--triazoles. Indian J. Chem. 2020, 59B, 1545–1555.
72. Khomenko, T.M.; Zarubaev, V.V.; Orshanskaya, I.R.; Kadyrova, R.A.; Sannikova, V.A.; Korchagina, D.V.; Volcho, K.P.; Salakhutdinov, N.F. Anti-influenza activity of monoterpene-containing substituted coumarins. Bioorg. Med. Chem. Lett. 2017, 27, 2920–2925.
73. Hu, Y.; Chen, W.; Shen, Y.; Zhu, B.; Wang, G.-X. Synthesis and antiviral activity of coumarin derivatives against infectious hematopoietic necrosis virus. Bioorg. Med. Chem. Lett. 2019, 29, 1749–1755.
74. Verdone, L.; Agricola, E.; Caserta, M.; Di Mauro, E. Histone acetylation in gene regulation. Brief. Funct. Genom. Proteom. 2006, 5, 209–221.
75. Pramanik, S.D.; Kumar Halder, A.; Mukherjee, U.; Kumar, D.; Dey, Y.N. Potential of histone deacetylase inhibitors in the control and regulation of prostate, breast and ovarian cancer. Front. Chem. 2022, 10, 847.
76. Abdizadeh, T.; Kalani, M.R.; Abnous, K.; Tayarani-Najaran, Z.; Khashyarmanesh, B.Z.; Abdizadeh, R.; Hadizadeh, F. Design, synthesis and biological evaluation of novel coumarin-based benzamides as potent histone deacetylase inhibitors and anticancer agents. Eur. J. Med. Chem. 2017, 132, 42–62.
77. Yang, F.; Zhao, N.; Song, J.; Zhu, K.; Jiang, C.; Shan, P.; Zhang, H. Design, synthesis and biological evaluation of novel coumarin-based hydroxamate derivatives as histone deacetylase (Hdac) inhibitors with antitumor activities. Molecules 2019, 24, 2569.
78. Zhao, N.; Yang, F.; Han, L.; Yuhua, Q.; Ge, D.; Zhang, H. Development of coumarin-based hydroxamates as histone deacetylase inhibitors with antitumor activities. Molecules 2020, 25, 717.
79. Ding, J.; Liu, J.; Zhang, Z.; Guo, J.; Cheng, M.; Wan, Y.; Wang, R.; Fang, Y.; Guan, Z.; Jin, Y.; et al. Design, synthesis and biological evaluation of coumarin-based N-hydroxycinnamide derivatives as novel histone deacetylase inhibitors with anticancer activities. Bioorg. Chem. 2020, 101, 104023.
80. Chang, C.; Lee, S.O.; Yeh, S.; Chang, T.M. Androgen receptor (AR) differential roles in hormone-related tumors including prostate, bladder, kidney, lung, breast and liver. Oncogene 2014, 33, 3225–3234.
81. Voet, A.; Helsen, C.; Zhang, K.Y.J.; Claessens, F. The discovery of novel human androgen receptor antagonist chemotypes using a combined pharmacophore screening procedure. ChemMedChem 2013, 8, 644–651.
82. Kandil, S.; Westwell, A.D.; McGuigan, C. 7-Substituted umbelliferone derivatives as androgen receptor antagonists for the potential treatment of prostate and breast cancer. Bioorg. Med. Chem. Lett. 2016, 26, 2000–2004.
83. Ma, C.-C.; Liu, Z.-P. Design and synthesis of coumarin derivatives as novel PI3K inhibitors. Anti-Cancer Agents Med. Chem. 2017, 17, 395–403.
84. Abdelnaby, R.M.; Rateb, H.S.; Ali, O.; Saad, A.S.; Nadeem, R.I.; Abou-Seri, S.M.; Amin, K.M.; Younis, N.S.; Abdelhady, R. Dual PI3K/Akt inhibitors bearing coumarin-thiazolidine pharmacophores as potential apoptosis inducers in MCF-7 cells. Pharmaceuticals 2022, 15, 428.
85. Khomenko, T.; Zakharenko, A.; Odarchenko, T.; Arabshahi, H.J.; Sannikova, V.; Zakharova, O.; Korchagina, D.; Reynisson, J.; Volcho, K.; Salakhutdinov, N.; et al. New inhibitors of tyrosyl-DNA phosphodiesterase I (Tdp 1) combining 7-hydroxycoumarin and monoterpenoid moieties. Bioorg. Med. Chem. 2016, 24, 5573–5581.
86. Khomenko, T.M.; Zakharenko, A.L.; Chepanova, A.A.; Ilina, E.S.; Zakharova, O.D.; Kaledin, V.I.; Nikolin, V.P.; Popova, N.A.; Korchagina, D.V.; Reynisson, J.; et al. Promising new inhibitors of tyrosyl-DNA phosphodiesterase I (Tdp 1) combining 4-arylcoumarin and monoterpenoid moieties as components of complex antitumor therapy. Int. J. Mol. Sci. 2020, 21, 126.
87. Kurt, B.Z.; Sonmez, F.; Ozturk, D.; Akdemir, A.; Angeli, A.; Supuran, C.T. Synthesis of coumarin-sulfonamide derivatives and determination of their cytotoxicity, carbonic anhydrase inhibitory and molecular docking studies. Eur. J. Med. Chem. 2019, 183, 111702.
88. Thacker, P.S.; Alvala, M.; Arifuddin, M.; Angeli, A.; Supuran, C.T. Design, synthesis and biological evaluation of coumarin-3-carboxamides as selective carbonic anhydrase IX and XII inhibitors. Bioorg. Chem. 2019, 86, 386–392.
89. Thacker, P.S.; Goud, N.S.; Argulwar, O.S.; Soman, J.; Angeli, A.; Alvala, M.; Arifuddin, M.; Supuran, C.T. Synthesis and biological evaluation of some coumarin hybrids as selective carbonic anhydrase IX and XII inhibitors. Bioorg. Chem. 2020, 104, 104272.
90. Wilkinson, B.L.; Bornaghi, L.F.; Houston, T.A.; Innocenti, A.; Supuran, C.T.; Poulsen, S.A. A novel class of carbonic anhydrase inhibitors: Glycoconjuate benzene sulfonamides prepared by “click-tailing”. J. Med. Chem. 2006, 49, 6539–6548.
91. Wilkinson, B.L.; Bornaghi, L.F.; Houston, T.A.; Innocenti, A.; Vullo, D.; Supuran, C.T.; Poulsen, S.A. Inhibition of membrane-associated carbonic anhydrase isozymes IX, XII and XIV with a library of glycoconjugate benzenesulfonamides. Bioorg. Med. Chem. Lett. 2007, 17, 987–992.
92. Wilkinson, B.L.; Bornaghi, L.F.; Houston, T.A.; Innocenti, A.; Vullo, D.; Supuran, C.T.; Poulsen, S.A. Carbonic anhydrase inhibitors: Inhibition of isozymes I, II, and IX with triazole-linked O-glycosides of benzene sulfonamides. J. Med. Chem. 2007, 50, 1651–1657.
93. Chu, N.; Wang, Y.; Jia, H.; Han, J.; Wang, X.; Hou, Z. Design, synthesis and biological evaluation of new carbohydrate-based coumarin derivatives as selective carbonic anhydrase IX inhibitors via “click” reaction. Molecules 2022, 27, 5464.
94. Shen, F.-Q.; Wang, Z.-C.; Wu, S.-Y.; Ren, S.-Z.; Man, R.-J.; Wang, B.-Z.; Zhu, H.-L. Synthesis of novel hybrids of pyrazole and coumarin as dual inhibitors of COX-2 and 5-LOX. Bioorg. Med. Chem. Lett. 2017, 27, 3653–3660.
95. Hua, W.; Zhao, J.; Hu, W.; Gou, S. Combination of 7-hydroxycoumarin in a platinum(IV) complex derived from cisplatin enhanced cytotoxicity with multiple mechanisms of action. J. Inorg. Biochem. 2018, 186, 17–23.
96. Qin, X.; Fang, L.; Zhao, J.; Gou, S. Theranostic Pt(IV) conjugate with target selectivity for androgen receptor. Inorg. Chem. 2018, 57, 5019–5029.
97. Wang, Q.; Chen, Y.; Li, G.; Liu, Z.; Ma, J.; Liu, M.; Li, D.; Han, J.; Wang, B. Synthesis and evaluation of bi-functional 7-hydroxycoumarin platinum(IV) complexes as antitumor agents. Bioorg. Med. Chem. 2019, 27, 2112–2121.
98. Bertrand, B.; de Almeida, A.; van der Burgt, E.P.M.; Picquet, M.; Citta, A.; Folda, A.; Rigobello, M.P.; Le Gendre, P.; Bodio, E.; Casini, A. New gold(I) organometallic compounds with biological activity in cancer cells. Eur. J. Inorg. Chem. 2014, 27, 4532–4536.
99. Arcau, J.; Andermark, V.; Aguiló, E.; Gandioso, A.; Moro, A.; Cetina, M.; Lima, J.C.; Rissanen, K.; Ott, I.; Rodríguez, L. Luminescent alkynyl-gold(I) coumarin derivatives and their biological activity. Dalton Trans. 2014, 43, 4426–4436.
100. Levin, P.P.; Liubimov, A.V.; Shashkov, A.S.; Mardaleishvili, I.R.; Venidiktova, O.V.; Shienok, A.L.; Koltsova, L.S.; Astafiev, A.A.; Barachevsky, V.A.; Zaichenko, N.L. Multiple fluorescence of tetraarylimidazole and azomethinocoumarin dyad with dual excited-state intramolecular proton transfer. Dyes Pigm. 2020, 183, 108716.
101. Xiao, Z.; Chen, D.; Song, S.; Vlag, R.; Wouden, P.; Merkerk, R.; Cool, R.H.; Hirsch, A.K.H.; Melgert, B.N.; Quax, W.J.; et al. 7-Hydroxycoumarins are affinity-based fluorescent probes for competitive binding studies of macrophage migration inhibitory factor. J. Med. Chem. 2020, 63, 11920–11933.
102. Shi, B.; Zhang, Z.; Jin, Q.; Wang, Z.; Tang, J.; Xu, G.; Zhu, T.; Gong, X.; Tang, X.; Zhao, C. Selective tracking of ovarian-cancer-specific γ-glutamyltranspeptidase using a ratiometric two-photon fluorescent probe. J. Mater. Chem. B 2018, 6, 7439.
103. Li, S.; Kan, W.; Zhao, B.; Liu, T.; Fang, Y.; Bai, L.; Wang, L. A fluorescent pH probe for an aqueous solution composed of 7-hydroxycoumarin, Schiff base and phenanthroimidazole moieties (PICO). Heterocycl. Commun. 2018, 24, 93–97.
104. Shukla, L.; Moodie, L.W.K.; Kindahl, T.; Hedberg, C. Synthesis and spectroscopic properties of fluorinated coumarin lysine derivatives. J. Org. Chem. 2018, 83, 4792–4799.
105. Gleason, P.R.; Kelly, P.I.; Grisingher, D.W.; Mills, J.H. An intrinsic FRET sensor of protein-ligand interactions. Org. Biomol. Chem. 2020, 18, 4079–4084.
106. Gleason, P.R.; Kolbaba-Kartchner, B.; Henderson, J.N.; Stahl, E.P.; Simmons, C.R.; Mills, J.H. Structural origins of altered spectroscopic properties upon ligand binding in proteins containing a fluorescent noncanonical amino acid. Biochemistry 2021, 60, 2577–2585.
107. Wang, K.; Yao, T.; Xue, J.; Guo, Y.; Xu, X. A novel fluorescent probe for the detection of hydrogen peroxide. Biosensors 2023, 13, 658.
108. Zhu, G.; Huang, Y.; Wang, C.; Lu, L.; Sun, T.; Wang, M.; Tang, Y.; Shan, D.; Wen, S.; Zhu, J. A novel coumarin-based fluorescence chemosensor for Al3+ and its application in cell imaging. Spectrochim. Acta Part A Mol. Biomol. Spectrosc. 2019, 210, 105–110.
109. Li, X.; Duan, Q.; Yu, Y.; Wang, K.; Zhu, H.; Zhang, X.; Liu, C.; Jia, P.; Li, Z.; Sheng, W.; et al. A coumarin-based fluorescent probe for Hg2+ and its application in living cells and zebrafish. Luminescence 2020, 35, 941–946.
110. Rojas-Montoyaa, S.M.; Vonlanthena, M.; Huerta-Roldána, J.M.; Aguilar-Ortíza, E.; Burillob, G.; Morales-Espinoza, E.G.; Rivera, E. Incorporation of photoluminescent 7-hydroxycoumarin units onto a polyethylene matrix by means of gamma radiation. Radiat. Phys. Chem. 2019, 163, 52–57.
111. Stefanachi, A.; Leonetti, F.; Pisani, L.; Catto, M.; Carotti, A. Coumarin: A natural, privileged and versatile scaffold for bioactive compounds. Molecules 2018, 23, 250.
112. Flores-Morales, V.; Villasana-Ruiz, A.P.; Garza-Veloz, I.; González-Delgado, S. Therapeutic effects of coumarins with different substitution patterns. Molecules 2023, 28, 2413.